Trials / Completed
CompletedNCT00865033
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions
A Relative Bioavailability Study of Metformin HCL 1000 mg Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the relative bioequivalence of Metformin HCL Tablets, 1000 mg under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin HCL Tablets, 1000 mg Sandoz | |
| DRUG | Glucophage 1000 mg |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2009-03-19
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00865033. Inclusion in this directory is not an endorsement.